
Science & Medicine: Sabotaging the molecular engines of some pediatric cancers
Update: 2025-09-21
Share
Description
A San Antonio researcher is working on a drug that could treat Ewing sarcoma and rhabdomyosarcoma without lifelong side effects. It would be the first new treatment option for these childhood cancers in 30 years.
Comments
In Channel






